Cosmetic & topical GHK-Cu Scalp Treatment What it supports A topical scalp treatment using copper peptide to support hair-follicle vitality, scalp health, and the bodys natural hair-growth cycle ideal for early thinning concerns
In 2025, Novo Nordisks semaglutide awaits several first-time FDA decisions: Injectable GLP-1s 2025 Ozempic for T2DM and peripheral artery disease (PAD) 2H 2025 Wegovy for heart failure with preserved ejection fraction (HFpEF) and obesity Oral GLP-1s October 2025 new indication for oral Rybelsus for secondary CV risk reduction 4Q 2025 the first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics (Prime) talented team of clinical experts actively monitors this emerging landscape
The problem with wrestling is youre always worried about the takedown, so that opens you up to strikes because youre always like, every feint, youre thinking hes going to shoot for your legs, but then, boom, he catches you with a left hook
Type 2 diabetes in adults: management NG28 Initial medicines chapter
These peptides are often incorporated into advanced skincare formulations to enhance their rejuvenating and anti-ageing effects
Increased survival with enzalutamide in prostate cancer after chemotherapy